ClinConnect ClinConnect Logo
Search / Trial NCT06349447

Pilot Study of LED for PIE and PIH

Launched by YANJUN DAN · Apr 4, 2024

Trial Information

Current as of June 04, 2025

Recruiting

Keywords

Photobiomodulation, Pie, Pih, Led

ClinConnect Summary

This clinical trial is looking at how special medical lights, called LEDs, can help prevent and treat two types of skin conditions known as Post-Inflammatory Erythema (PIE) and Post-Inflammatory Hyperpigmentation (PIH), which can cause dark spots on the skin. The study is open to healthy Asian adults aged 20 to 65 who have specific skin types. Participants will need to sign a consent form agreeing to take part in the study.

To join, you must not have any serious skin or health issues, be free from certain medications, and not be pregnant or breastfeeding. If you decide to participate, you can expect to receive treatment using these LEDs and help researchers learn more about their effectiveness. This study is currently recruiting participants, so if you meet the criteria, you could contribute to important research in skin health!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Healthy Asians;
  • 2. 20-65 years old;
  • 3. Fitzpatrick classification III-IV;
  • 4. Sign the informed consent form.
  • Exclusion Criteria:
  • 1. Have abnormal skin manifestations, such as pigment diseases, photosensitivity diseases and other allergic diseases;
  • 2. Those with a history of abnormal systemic diseases, such as heart disease, liver disease, kidney disease, tumors, and mental illness;
  • 3. Women who are preparing for pregnancy, pregnant or breastfeeding;
  • 4. Have used photosensitizing drugs within two weeks before inclusion in this study;
  • 5. Topical or systemic drugs may be used during this study;
  • 6. bad habits, such as smoking, drinking, etc.;
  • 7. Volunteers who have recently participated in other clinical trials;

About Yanjun Dan

Yanjun Dan is a dedicated clinical trial sponsor committed to advancing medical research and innovation through rigorous clinical studies. With a focus on enhancing patient outcomes and safety, Yanjun Dan collaborates with healthcare professionals, researchers, and regulatory bodies to design and implement trials that adhere to the highest ethical and scientific standards. The organization emphasizes transparency, integrity, and collaboration, striving to contribute valuable insights to the scientific community and improve therapeutic options for patients worldwide.

Locations

Shanghai, , China

Patients applied

0 patients applied

Trial Officials

Leihong Xiang, professor

Principal Investigator

Huashan Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported